Top Markets
Coin of the day
Sartorius Aktiengesellschaft Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

SOAGY
Rank in Stocks #317
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and... Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in GΓΆttingen, Germany.
Share Price
$47.54
Market Cap
$69.46B
Change (1 day)
-3.59%
Change (1 year)
-9.07%
Country
DE
Trade Sartorius Aktiengesellschaft (SOAGY)

Category

Revenue for Sartorius Aktiengesellschaft (SOAGY)
Revenue in Dec 2025 TTM: $4.14B
According to Sartorius Aktiengesellschaft latest financial reports the company's current revenue (TTM) is $4.14B. In 2023 the company made a revenue of $3.75B a decrease compared to the revenue in the year 2022 that was $4.48B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sartorius Aktiengesellschaft from 2002 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $4.14B 17.65%
2024 $3.52B -6.29%
2023 $3.75B -16.17%
2022 $4.48B 14.17%
2021 $3.92B 37.89%
2020 $2.84B 38.77%
2019 $2.05B 13.90%
2018 $1.80B 6.78%
2017 $1.69B 23.18%
2016 $1.37B 13.03%
2015 $1.21B 12.26%
2014 $1.08B -0.94%
2013 $1.09B -2.42%
2012 $1.12B 17.55%
2011 $949.02M 7.66%
2010 $881.50M 2.11%
2009 $863.31M 1.28%
2008 $852.37M -1.00%
2007 $860.99M 25.58%
2006 $685.60M 19.81%
2005 $572.23M -9.74%
2004 $633.99M 13.84%
2003 $556.93M 11.37%
2002 $500.05M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$10.06B 143.19%
US
$21.92B 429.71%
US
$5.91B 42.80%
JP
$10.40B 151.31%
CH
$5.40B 30.43%
US